One study reported that CHK1 can activate the pSTAT3-CIP2A oncogenic circuit in GBM, which prompted us to hypothesis that the growth of GBM may be inhibited by targeting KIAA152419. The gene discussed is CHEK1; the disease is glioblastoma.